Bionano Genomics (BNGO) Stock Sees Selling Pressure At Higher Level

The Bionano Genomics (NASDAQ:BNGO) stock has come back in the news week after the company announced yesterday that its management is going to make a presentation at a key industry event. The announcement proved to be a major boost for the Bionano stock, which jumped by 7% yesterday.

The company announced that it is going to make a presentation virtually at the 2021 Ladenburg Thalmann Healthcare Conference that is going to be held from July 13 to July 14. The Chief Executive Officer of Bionano, Erik Holmlin is going to make a presentation on the overview of the company at 4 p.m. EDT on July 13.

It is a significant development for the company since it is expected to give it considerable exposure to other players in the industry and possibly to new investors as well. Hence, the excitement about the stock is also understandable.

Earlier on in the week, the company got another boot after it emerged that the Bionano stock had been added to the Russell 2000 Index which is meant for United States small cap stocks. The Russell indexes were reconstituted as part of an annual routine and Bionano was made a part of this particular index.

Market Reaction:

On Thursday, BNGO stock fell 7% to $6.82 with more than 19.48 million shares, compared to  its average volume of 23.88 million shares. The stock has moved within a range of $6.71 – 7.31 after opening the trade at $7.31. Over the past 52-week, the stock has been trading within a range of $0.45 – 15.69.

Related Posts

About The Author